Best IVF and Fertility Clinics in Indonesia

The IVF success rate in Indonesia varies depending on the mother’s age, with recent data indicating rates from 31% to 55%. National averages have shown improvement over the years, and some clinics report figures that are comparable to international standards.

In 2017, the national average IVF success rate was 29%. More recent data from Bocah Indonesia in 2024 shows a 55% pregnancy success rate for mothers under 35, 48% for those aged 35-39, and 31% for those 40 and above. A study from 2011-2020 found the overall pregnancy rate ranged between 24.6% and 37.3% for all ages, while another study in 2019 reported rates of 35.70% for those under 30, decreasing to 14.50% for women over 43.

Bocah Indonesia reports their success rates are achieved using the couple’s own eggs and sperm, and internationally, IVF with donor eggs often shows higher success rates, particularly with increasing maternal age, potentially ranging from 40% to 60% or even above 75% per embryo transfer with young donors. Bocah Indonesia’s reported rates are noted as being higher than the average rates reported by the UK’s HFEA.

Reciprocal IVF (ROPA) is not permitted in Indonesia under the current legal framework, as regulations restrict IVF treatment to legally married, heterosexual couples.

Indonesian law requires that both eggs and sperm used in IVF originate from the couple undergoing treatment, which prohibits gamete donation, surrogacy, and uterine transplantation; therefore, ROPA, which necessitates donor sperm, is not legally allowed. Parental recognition is also tied to the legality of the marriage, and as ROPA is not permitted for same-sex couples, the issue of parental recognition for both partners in a ROPA scenario does not arise within the current legal context.

Although clinics like Morula IVF Indonesia, Bocah Indonesia, and Brawijaya Women & Children Hospital offer IVF services, they operate under the existing regulations that limit IVF to legally married, heterosexual couples, and no clinics are known to offer ROPA within Indonesia.

In Indonesia, there is no specific legal maximum age for undergoing IVF, but medical and ethical factors, as well as individual clinic policies, play a significant role in determining eligibility.

While there isn’t a strict legal upper age limit, fertility generally declines with age, with the optimal range for IVF success being between 25 and 35 years old. Success rates decrease after 35, and can be around 10-15% per cycle by age 40, and 15-20% for women over 45, though specialized approaches may be available. Some clinics may not offer treatment to women aged 40 and above, while others assess each case individually based on overall health and medical factors, so direct consultation with clinics is recommended.

It is important to note that Indonesian law prohibits the use of donor eggs, sperm, or embryos, meaning all gametes must come from the legally married couple, and there are therefore no separate age limits for using own eggs versus donor eggs.

IVF is legal in Indonesia, but only for legally married couples, and is subject to specific regulations.

The practice of assisted reproductive technology, including IVF, is governed by Indonesian Law Number 36 of 2009 concerning health, and Law No. 17 of 2023 on Health, with further guidance provided by Ministry of Health (MOH) Regulation No. 2 of 2025. These laws require proof of legal marriage and stipulate that both the sperm and eggs used in the IVF process must come from the couple themselves, prohibiting the use of donor gametes or surrogacy.

Furthermore, IVF procedures can only be carried out in hospitals and clinics specifically licensed by the Ministry of Health, and any excess embryos created during the process must be stored until the birth of a child, with the possibility of extending the storage period for future pregnancies.

Currently, gay couples face significant legal and practical obstacles to accessing IVF treatment in Indonesia, as the procedures are generally restricted to legally married heterosexual couples.

While IVF and assisted reproductive technologies are available in Indonesia at clinics such as Morula IVF, Abdi Waluyo Hospital, and Bocah Indonesia, a key requirement is legal marriage, which is not permitted for same-sex couples. Furthermore, although gamete donation is technically permitted, it is rarely practiced due to legal interpretations and religious beliefs, and Indonesian health guidelines restrict gamete use to the couple seeking treatment. Surrogacy is explicitly prohibited by Indonesian law, adding another barrier for same-sex couples hoping to start a family through assisted reproduction.

Indonesia does not legally recognize same-sex marriage or any equivalent partnerships, which further complicates parental recognition and adoption rights for same-sex couples, impacting their ability to establish legal parentage for children conceived through any means.

Lesbian couples are not eligible for IVF treatment in Indonesia, as the law requires individuals undergoing IVF to be legally married, and same-sex marriage is not legally recognized in the country.

Indonesian law, specifically Law Number 36 of 2009, mandates that IVF services are exclusively available to heterosexual married couples. Because same-sex couples are not recognized legally, they do not have the legal status required to access these treatments. Furthermore, sperm donation is not legally recognized and a proposed bill seeks to criminalize it, adding another barrier to access for lesbian couples seeking to utilize donor sperm in IVF.

Legal parentage in Indonesia is determined by lawful marriage between a man and a woman, meaning there is no legal framework to recognize both partners in a lesbian relationship as parents to a child conceived through ART. Restrictions on IVF, sperm donation, surrogacy, and third-party gametes are heavily influenced by religious and moral considerations within the country.

Sperm donation is strictly prohibited in Indonesia, and a proposed bill from 2020 sought to criminalize the practice.

Article 31 of the proposed bill on family resilience stipulated penalties for those involved in sperm donation, including fines up to Rp 500 million (approximately US$36,531) and imprisonment for up to five years for donors, and up to seven years for facilitators or those who coerce others. The Indonesian Ulemas Forum (MUI) has also declared sperm banks “haram,” citing moral and religious concerns regarding the origin and identity of children born through sperm donation.

Because sperm donation is illegal, there are no legally defined donor requirements or established compensation policies in Indonesia, although international sperm banks generally have stringent criteria for donors, such as age, health, and comprehensive medical screenings.

Surrogacy is prohibited in Indonesia, and there are no laws currently in place to legalize or regulate the practice.

Both altruistic and commercial surrogacy are considered illegal and are often carried out secretly, typically involving family members. Under Indonesian law, a child born through surrogacy is legally recognized as the child of the surrogate mother, not the intended parents, and intended parents would need to pursue adoption to establish legal parentage.

While specific penalties for individuals are not clearly defined, medical professionals providing surrogacy services face severe consequences, and surrogacy agreements are considered legally invalid. The practice is also viewed as conflicting with religious and cultural norms in Indonesia.

Currently, single women cannot legally undergo IVF in Indonesia due to regulations that restrict the procedure to legally married couples.

Indonesian law, specifically Law Number 36 of 2009 concerning health, permits IVF but only for married couples. Furthermore, practices like sperm donation and surrogacy, which would be necessary for a single woman to pursue IVF, are strictly prohibited and carry significant legal penalties. The prohibition of sperm donation is rooted in its classification as human organ trading, leading to legal complexities surrounding parentage and inheritance.

While there are no specific age limits defined for single women regarding IVF access (as it is not permitted), success rates for IVF in Indonesia generally decline with age, ranging from 35-55% for women aged 25-30 to 15-21% for those over 40. Public funding for family planning does not extend to single individuals seeking fertility treatments like IVF.

Embryo donation is not explicitly regulated or permitted under current Indonesian law, as the legal framework emphasizes that eggs and sperm must originate from the intended parents.

The legal basis for assisted reproductive technology (ART) in Indonesia includes Law Number 36 of 2009 concerning Health, Law No. 17 of 2023, and Government Regulation No. 28 of 2024, but these laws do not contain specific provisions addressing embryo donation. There is a general absence of national legislation directly addressing this practice.

While anonymity is mandated for sperm and egg donors, the lack of specific laws regarding embryo donation means that anonymity rules in this context are not clearly defined, though the existing principles suggest identification of embryo donors would likely not be permitted.

In Indonesia, gender selection for non-medical reasons using IVF is a complex issue with varying interpretations and practices. While some clinics may offer gender selection through Preimplantation Genetic Testing (PGT), the legal and ethical framework surrounding this practice is not as clearly defined as in some other countries.

Currently, Indonesian regulations permit sex selection using Assisted Reproductive Technology (ART) primarily based on the sequence of children, allowing it for the second child without explicitly differentiating between medical and non-medical reasons. This approach was regulated by Government Regulation No. 61, Article 44, 2014 on Reproductive Health. However, there are differing professional opinions, with the Indonesian Society of Obstetrics and Gynecological (POGI) suggesting that sex selection in ART should be implemented only for medical reasons.

For medical reasons, gender selection is ethically acceptable and is used to avoid the transmission of sex-linked hereditary diseases, such as hemophilia or Duchenne muscular dystrophy. PGT is a method used to test embryos for genetic abnormalities, including their sex, before implantation. This allows for the selection of embryos free from specific genetic conditions that are linked to a particular gender.

While some sources indicate that gender selection is possible through PGT in Indonesia, the broader ethical and legal landscape remains a point of discussion. The practice of non-medical sex selection is generally controversial internationally, with many countries prohibiting it due to concerns about gender discrimination and the potential for eugenics.

The cost of In Vitro Fertilization (IVF) in Indonesia offers a more affordable alternative compared to many Western countries, with prices varying based on the clinic, treatment plan, and any additional procedures required. Generally, a complete IVF cycle can range from approximately $2,000 to $7,000 USD.

The price for a basic IVF cycle in Indonesia typically falls between $2,000 and $4,600 USD, with some sources indicating a range of $2,000 to $4,500 USD. These packages often include essential services such as initial consultations, fertility examinations, hormonal medications, egg retrieval, and fertilization.

Information regarding the specific cost of IVF with egg donation in Indonesia is not readily available in the provided search results. However, in other regions, egg donation programs can range from $5,000 to $8,000 USD.

Medication costs for IVF in Indonesia are estimated to be between $35 to $50 USD.

ICSI is frequently offered as a package with IVF, with prices for IVF-ICSI packages ranging from $2,000 to $4,660 USD. Some sources suggest that ICSI itself can add an average of $1,500 to $3,000 USD to the overall cost in the US, covering specialized work and equipment. Globally, ICSI cycles can range from $3,000 to over $25,000 USD, with location being a major factor.

PGT services are available in Indonesia, with PGT-A charges estimated between $500 to $700 USD. This procedure is typically performed if specific conditions are present in the parents and is often not included in standard IVF packages. In other regions, PGT-A testing, including assisted hatching and biopsy per embryo, can cost between 515 EUR and 580 EUR (approximately $550-$630 USD).